MAPT and Alzheimer disease: This hypothesis suggests, on the one hand, that BBB breakdown could be an early biomarker of human cognitive dysfunction independent of Aβ and tau, and that infiltration of immune cells from the periphery might play a key role in AD inflammation and neurodegeneration, on the other.